Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2008-08-15

FDA Approved: HYDROCHLOROTHIAZIDE — Original Application (Exelan Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved Exelan Pharmaceuticals Inc.'s original application for hydrochlorothiazide, a generic diuretic indicated for hypertension and edema-related con…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HYDROCHLOROTHIAZIDE (hydrochlorothiazide)

Snippet

ORIG AP for HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE)